NCT00909402: A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas |
|
|
| Completed | 1b | 39 | US, Canada, Europe | BMS-833923, Cisplatin, Platinol-AQ, Capecitabine, Xeloda | Bristol-Myers Squibb, Exelixis | Stomach Neoplasms, Esophageal Neoplasms | 11/12 | 11/12 | | |
